{"transactions":[{"id":2134374,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":122998,"kind":"person","name":"Delaney David","position":1,"cik":"0001943013","reported_name":"Delaney David","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}},{"id":122999,"kind":"organization","name":"Concord IP2 Ltd.","position":2,"cik":"0001943018","reported_name":"Concord IP2 Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}},{"id":123000,"kind":"organization","name":"Elderhill Corp","position":3,"cik":"0001943046","reported_name":"Elderhill Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}}],"security":"Common Stock","published_at":"2022-10-19T21:29:22.000Z","date":"2022-10-17","kind":"purchase","acquired":true,"shares":1000,"price":1.11,"value":1110.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were purchased by Elderhill Corporation, of which David Delaney serves as sole director and President."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 36,200 shares are held by Elderhill Corporation."}],"balance_after":227521,"source":{"system":"sec-edgar","filing":"0001209191-22-054100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841330/000120919122054100/doc4.xml","form_type":"4"}}]}